To date, the publications have reported that BRAF mutations was found in 25%-60% of CM, NARS mutations in 18-20% of CM, NF1 mutations in 20%-33% of CM, and TERT promoter mutations in 20%-41% of CM (10, 40–45). This evidence concerns the gene BRAF and cutaneous mastocytosis.